Immunotherapy targeting intracellular pathogens
US10982196B2 · kind B2 · utility
2Cited by
22References
18Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Aug 4, 2014 |
| Grant date | Apr 20, 2021 |
| Priority date | — |
| Expiry date | Nov 8, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y108/01009
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of immunogenic peptides comprising a T-cell epitope derived from an intracellular pathogen-associated antigen and a redox motif such as C-(X)2-[CST] or [CST]-(X)2-C in the prevention and/or treatment of infection with an intracellular pathogen and in the manufacture of medicaments therefore.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.